AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
Log in

NASDAQ:PGNXProgenics Pharmaceuticals Insider Trades

$4.10
0.00 (0.00 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.10
Now: $4.10
$4.10
50-Day Range
$3.63
MA: $4.16
$4.62
52-Week Range
$1.89
Now: $4.10
$6.37
VolumeN/A
Average Volume1.16 million shs
Market Capitalization$355.05 million
P/E RatioN/A
Dividend YieldN/A
Beta1.89

Insider Trades

Progenics Pharmaceuticals (NASDAQ:PGNX) Insider Buying and Selling Activity

Insider Ownership Percentage: 4.26%

Insider Buying and Selling by Quarter


Progenics Pharmaceuticals (NASDAQ PGNX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2019Lte Partners, LlcInsiderBuy21,480$4.94$106,111.20  
9/5/2019Lte Partners, LlcInsiderBuy43,520$4.62$201,062.40  
9/3/2019Velan Capital, L.P.InsiderBuy277,424$4.39$1,217,891.36  
8/26/2019Velan Capital, L.P.InsiderBuy204,056$4.31$879,481.36  
8/23/2019Velan Capital, L.P.InsiderBuy130,826$4.31$563,860.06  
2/15/2017Healthcare Master Fun BroadfinMajor ShareholderSell602,600$9.66$5,821,116.00  
2/9/2017Healthcare Master Fun BroadfinMajor ShareholderSell351,300$9.71$3,411,123.00  
6/11/2015Robert J IsraelEVPSell2,000$6.83$13,660.00  
3/13/2015Robert J IsraelEVPSell3,000$7.00$21,000.00  
3/11/2015Robert J IsraelEVPSell2,000$6.83$13,660.00  
3/3/2015Robert J IsraelEVPSell5,000$6.49$32,450.00  
1/12/2015Robert J IsraelEVPSell2,000$7.06$14,120.00  
12/11/2014Robert J IsraelEVPSell3,000$7.07$21,210.00  
11/21/2014Robert J IsraelEVPSell9,000$7.00$63,000.00  
11/13/2014Robert J IsraelEVPSell10,000$6.83$68,300.00  
11/11/2014Robert J IsraelEVPSell5,000$6.53$32,650.00  
7/21/2014Healthcare Master Fun BroadfinMajor ShareholderBuy1,625,436$4.60$7,477,005.60  
7/18/2014Healthcare Master Fun BroadfinMajor ShareholderBuy388,200$4.73$1,836,186.00  
7/17/2014Healthcare Master Fun BroadfinMajor ShareholderBuy436,884$4.48$1,957,240.32  
7/16/2014Healthcare Master Fun BroadfinMajor ShareholderBuy411,693$4.48$1,844,384.64  
7/18/2013Robert J IsraelVPSell5,000$6.33$31,650.00  
2/27/2013Mark Robert BakerCEOBuy1,262$2.72$3,432.64  
1/22/2013Mark Robert BakerCEOBuy1,215$2.82$3,426.30  
12/26/2012Mark Robert BakerCEOBuy1,142$3.01$3,437.42  
11/28/2012Mark Robert BakerCEOBuy1,607$2.13$3,422.91  
11/19/2012Mark Robert BakerCEOBuy11,800$1.96$23,128.00  
11/16/2012Mark Robert BakerCEOBuy49,793$1.82$90,623.26  
11/15/2012Mark Robert BakerCEOBuy48,833$1.69$82,527.77  
10/24/2012Mark Robert BakerCEOBuy1,162$2.96$3,439.52  
9/26/2012Mark Robert BakerCEOBuy1,036$3.32$3,439.52  
(Data available from 1/1/2013 forward)
This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.